Laerdal Million Lives Fund — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
Cardiosensecardiosense.comin𝕏Nov 2022
Cardiosense develops the CardioTag, a noninvasive point-of-care cardiac monitoring device that measures pulmonary capillary wedge pressure to enable early detection and management of worsening heart failure across emergency, inpatient, and outpatient settings.
AI & Machine LearningDigital HealthMedical DevicesChicago, US
Omer Tolga Inan(Director)Amit K. Gupta(Executive Officer, Director)Andrew Michael Carek(Executive Officer)
BoardJeff Terrell(Director)Daniel Gottlieb(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.